Angiogenin mediates androgen-stimulated prostate cancer growth and enables castration resistance
- PMID: 23851444
- PMCID: PMC3800479
- DOI: 10.1158/1541-7786.MCR-13-0072
Angiogenin mediates androgen-stimulated prostate cancer growth and enables castration resistance
Abstract
The androgen receptor (AR) is a critical effector of prostate cancer development and progression. Androgen-dependent prostate cancer is reliant on the function of AR for growth and progression. Most castration-resistant prostate cancer (CRPC) remains dependent on AR signaling for survival and growth. Ribosomal RNA (rRNA) is essential for both androgen-dependent and castration-resistant growth of prostate cancer cells. During androgen-dependent growth of prostate cells, androgen-AR signaling leads to the accumulation of rRNA. However, the mechanism by which AR regulates rRNA transcription is unknown. Here, investigation revealed that angiogenin (ANG), a member of the secreted ribonuclease superfamily, is upregulated in prostate cancer and mediates androgen-stimulated rRNA transcription in prostate cancer cells. Upon androgen stimulation, ANG undergoes nuclear translocation in androgen-dependent prostate cancer cells, where it binds to the rDNA promoter and stimulates rRNA transcription. ANG antagonists inhibit androgen-induced rRNA transcription and cell proliferation in androgen-dependent prostate cancer cells. Interestingly, ANG also mediates androgen-independent rRNA transcription through a mechanism that involves its constitutive nuclear translocation in androgen-insensitive prostate cancer cells, resulting in a constant rRNA overproduction and thereby stimulating cell proliferation. Critically, ANG overexpression in androgen-dependent prostate cancer cells enables castration-resistant growth of otherwise androgen-dependent cells. Thus, ANG-stimulated rRNA transcription is not only an essential component for androgen-dependent growth of prostate cancer but also contributes to the transition of prostate cancer from androgen-dependent to castration-resistant growth status.
Implications: The ability of angiogenin to regulate rRNA transcription and prostate cancer growth makes it a viable target for therapy.
Conflict of interest statement
Figures






Similar articles
-
NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer.Cancer Biol Ther. 2015;16(2):287-96. doi: 10.1080/15384047.2014.1002348. Cancer Biol Ther. 2015. PMID: 25756511 Free PMC article.
-
Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription.Oncogene. 2018 Jun;37(25):3340-3355. doi: 10.1038/s41388-018-0198-z. Epub 2018 Mar 20. Oncogene. 2018. PMID: 29555975 Free PMC article.
-
Restoration of the cellular secretory milieu overrides androgen dependence of in vivo generated castration resistant prostate cancer cells overexpressing the androgen receptor.Biochem Biophys Res Commun. 2016 Jul 22;476(2):69-74. doi: 10.1016/j.bbrc.2016.05.058. Epub 2016 May 12. Biochem Biophys Res Commun. 2016. PMID: 27179779
-
Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.Oncotarget. 2017 Jan 10;8(2):3724-3745. doi: 10.18632/oncotarget.12554. Oncotarget. 2017. PMID: 27741508 Free PMC article. Review.
-
Androgen receptors in hormone-dependent and castration-resistant prostate cancer.Pharmacol Ther. 2013 Dec;140(3):223-38. doi: 10.1016/j.pharmthera.2013.07.003. Epub 2013 Jul 13. Pharmacol Ther. 2013. PMID: 23859952 Review.
Cited by
-
Angiogenin negatively regulates the expression of basic fibroblast growth factor (bFGF) and inhibits bFGF promoter activity.Int J Clin Exp Pathol. 2018 Jul 1;11(7):3277-3285. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31949702 Free PMC article.
-
Rodent models of osteoporosis.Bonekey Rep. 2014 Dec 10;3:614. doi: 10.1038/bonekey.2014.109. eCollection 2014. Bonekey Rep. 2014. PMID: 25852854 Free PMC article.
-
Deciphering the biophysical aspects of the interaction of 3,5,4'-trihydroxy-trans-stilbene with ribonuclease A: spectroscopic and computational studies.Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):5773-5783. doi: 10.1007/s00210-024-03664-w. Epub 2024 Nov 28. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39607551
-
Angiogenin stimulates ribosomal RNA transcription by epigenetic activation of the ribosomal DNA promoter.J Cell Physiol. 2014 Apr;229(4):521-9. doi: 10.1002/jcp.24477. J Cell Physiol. 2014. PMID: 24122807 Free PMC article.
-
RNA biology of angiogenin: Current state and perspectives.RNA Biol. 2017 Feb;14(2):171-178. doi: 10.1080/15476286.2016.1272746. RNA Biol. 2017. PMID: 28010172 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous